SonoThera

About

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

San Francisco,California,United States
11 - 50
https://sonothera.com

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $60.75M
Industries: Biopharma,Biotechnology,Genetics,Medical
Founded date: Jan 1, 1982
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: SonoThera, Inc.

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease.
SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$60.75M

SonoThera has raised a total of $60.75M in funding over 2 rounds. Their latest funding was raised on Dec 5, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 5, 2022	Series A	$60.75M	11	ARCH Venture Partners	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

11

SonoThera is funded by 11 investors. ARCH Venture Partners and Alexandria Venture Investments are the most recent investors.

Investor Name	Lead Investor	Funding Round
ARCH Venture Partners	Yes	Series A
Alexandria Venture Investments	—	Series A
Eli Lilly & Company Foundation	—	Series A
Foothill Ventures	—	Series A
Formic Ventures	—	Series A
Illumina Ventures	—	Series A
Johnson & Johnson Innovation – JJDC	—	Series A
Lifespan Investments	—	Series A
Medical Excellence Capital	—	Series A
Vertex Ventures HC	—	Series A